TY  - CHAP
M1  - Book, Section
TI  - Hepatocellular Carcinoma
A1  - Uemura, Marc
A1  - Krishnan, Sunil
A1  - Kaseb, Ahmed O.
A1  - Bhadkamkar, Nishin A.
A1  - Javle, Milind M.
A1  - Avritscher, Rony
A2  - Kantarjian, Hagop M.
A2  - Wolff, Robert A.
PY  - 2016
T2  - The MD Anderson Manual of Medical Oncology, 3e
AB  - Hepatobiliary  malignancies  comprise  a  diverse  group  of  tumors,  including  hepatocellular  carcinoma  (HCC),  variants  such  as  fibrolamellar  HCC  (FLHCC)  and  cholangiocellular  carcinoma,  cholangiocarcinoma,  carcinoma  of  the  gallbladder,  and  rare  cancers  such  as  sarcoma,  angiosarcoma,  and  hepatoblastoma.  The  relative  frequency  of  these  tumors  is  shown  in  Table  22-1.  The  estimated  new  cases  and  deaths  from  liver  and  intrahepatic  bile  duct  cancer  in  the  United  States  in  2014  totaled  33,190  and  23,000,  respectively  (1).  
SN  - 
PB  - McGraw-Hill Medical
CY  - New York, NY
Y2  - 2024/04/20
UR  - hemonc.mhmedical.com/content.aspx?aid=1126742315
ER  -